BTK and neoplasm: In addition, strategies to combat resistance to BTK inhibitors include combination with other targeted drugs, reduction of BTK content, inhibition of upstream and downstream pathways of BTK, combination with CAR-T cell immunotherapy, and implementation of other pathways to inhibit the proliferation of tumor cells.